The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Stonepine Capital, L.p. since 2015.
The trader's CIK number is 1370042.
At the time of the last reporting, Stonepine Capital, L.p. was the Officer of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF).
Also see all insider trading activities at Novelion Therapeutics Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | NVLNF | 205,787 | $143,039 | 0 | $0 | 0 | $0 |
2016 | NVLNF | 133,496 | $206,537 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | APEN | 380,275 | $1,826,259 | 750,000 | $2,250,000 | 0 | $0 |
2017 | APEN | 190,444 | $923,538 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | VIVMF | 2,857,142 | $1,999,999 | 0 | $0 | 0 | $0 |
1. Novelion Therapeutics Inc. (NVLNF)
2. Apollo Endosurgery, Inc. (APEN)
3. Viveve Medical, Inc. (VIVMF)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-12-12 | NVLNF | Buy | 1,000 | .70 | 700 |
2019-12-10 | NVLNF | Buy | 5,202 | .69 | 3,599 |
2019-12-11 | NVLNF | Buy | 40 | .69 | 27 |
2019-12-05 | NVLNF | Buy | 5,160 | .70 | 3,611 |
2019-12-06 | NVLNF | Buy | 40 | .70 | 28 |
2019-12-09 | NVLNF | Buy | 4,500 | .70 | 3,150 |
2019-11-22 | NVLNF | Buy | 89,845 | .75 | 67,024 |
2019-10-11 | NVLNF | Buy | 100,000 | .65 | 64,900 |
2016-09-13 | QLTI | Buy | 61,704 | 1.54 | 95,147 |
2016-09-14 | QLTI | Buy | 56,864 | 1.55 | 88,252 |
2016-09-15 | QLTI | Buy | 14,928 | 1.55 | 23,138 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-12-27 | APEN | Sale | 250,000 | 3.00 | 750,000 |
2018-12-26 | APEN | Sale | 500,000 | 3.00 | 1,500,000 |
2018-11-19 | APEN | Buy | 54,200 | 3.40 | 184,280 |
2018-11-21 | APEN | Buy | 3,230 | 3.60 | 11,644 |
2018-11-02 | APEN | Buy | 300,000 | 5.00 | 1,500,000 |
2017-12-29 | APEN | Buy | 5,163 | 5.56 | 28,716 |
2018-01-02 | APEN | Buy | 11,343 | 5.73 | 64,961 |
2018-01-03 | APEN | Buy | 6,339 | 5.78 | 36,658 |
2017-12-26 | APEN | Buy | 5,287 | 5.00 | 26,435 |
2017-12-22 | APEN | Buy | 41,399 | 5.00 | 206,870 |
2017-12-21 | APEN | Buy | 98,324 | 4.94 | 485,917 |
2017-12-20 | APEN | Buy | 45,434 | 4.50 | 204,316 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-11-24 | VIVMF | Buy | 2,857,142 | .70 | 1,999,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stonepine Capital, L.p. (Officer of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.